Schizophrenia Clinical Trial
Official title:
Effect of Repetitive Transcranial Magnetic Stimulation (RTMS) on Resting State Brain Activity in Schizophrenia
This study compares the efficacy of low and high frequency repetitive transcranial magnetic stimulation (rTMS) as a means of treating subjects with schizophrenia. Magnetic pulses delivered over the scalp cause brain activity. This activity has been shown to help decrease the intensity and frequency of auditory hallucinations (AH) in schizophrenia. The investigators will compare whether low or high frequencies work best. The investigators will also examine what changes occur in the brain that are related to improvement.
Background. The sub-Investigator Dr. Mennemeier has been using repetitive transcranial
magnetic stimulation (rTMS) to treat phantom sound perception in subjects with tinnitus. The
Principal Investigator (PI), Dr. Messias, now aims to team up with Drs. Mennemeier and
James, to learn how rTMS influences phantom sound perception in schizophrenia. rTMS has
already been shown to be an effective treatment for both tinnitus and schizophrenia. rTMS is
a non-invasive method of regional brain stimulation that can significantly reduce phantom
sound perception temporarily in 50% of subjects with tinnitus and schizophrenia. This study
will go further than previous investigations by analyzing how different frequencies of rTMS
influence not only auditory hallucinations (AH) in schizophrenia but also brain connectivity
in schizophrenia. The investigators want to learn if rTMS decreases AH by normalizing brain
connectivity. Whereas this study focuses on schizophrenic subjects with AH, the design is
very similar to ongoing work on tinnitus so the findings will be comparable.
Tinnitus and AH in schizophrenia are prevalent and disabling disorders of sound perception.
The investigators understanding of the precise mechanisms of these disorders is lacking.
Interestingly, the symptoms of both disorders respond positively to rTMS of the temporal
cortex in ways that defy contemporary understanding of the nature of these symptoms and of
how rTMS should work to improve them. For example, phantom sound perception in both tinnitus
and schizophrenia are linked to maladaptive, hyperactivity of auditory processing regions of
temporal cortex; however, it is increasingly clear that these pathological changes alone are
insufficient to explain the pronounced intrusiveness and negative emotional valance of
symptoms in each disorder. Therefore, a barrier to understanding these disorders lies in
understanding how changes in auditory cortex are synchronized with changes in other cortical
regions that regulate perception and emotion. Additionally, at present, the decision of
which rTMS frequency to apply as a treatment for phantom sound perception has no firm
theoretical or empirical basis. Whereas, low frequency rTMS has traditionally been used,
based upon contemporary models, to "inhibit" hyperactivity in auditory cortex; high
frequency rTMS, which should induce an opposite effect on neuronal processing, not only
works to improve symptoms but may be more effective for some subjects than low frequency
rTMS. Therefore, contemporary models designed to explain how the frequency of rTMS
influences neuronal activity immediate following stimulation are insufficient to explain how
low and high frequencies of rTMS can mitigate phantom sound perception for days, weeks and
months following a single course of treatment.
Hypothesis. The investigators propose that phantom sound perception in schizophrenia result
from an imbalance of excitatory and inhibitory neural process in auditory networks and from
synchronized, maladaptive changes in linked brain regions that regulate perception and
emotion. Treating auditory cortex with repetitive, external magnetic stimulation can
decrease phantom sound perception and distress by reversing the maladaptive brain
reorganization that is set in motion by these underlying neural imbalances.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |